Clinical Trial Update: Two Intermediate Expanded Access Protocols (EAP) CNMAu8.EAP01 and CNMAu8.EAP02 for ALS

View source ↗

Summary

Two intermediate Expanded Access Protocols for CNM-Au8 (CNMAu8.EAP01 and CNMAu8.EAP02) in amyotrophic lateral sclerosis are no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• CNM-Au8 (CNM-Au8)

Snippet

Sponsor: Clene Nanomedicine | Conditions: Amyotrophic Lateral Sclerosis | Status: NO_LONGER_AVAILABLE